MethodsX (Jan 2020)

Primary pulmonary arterial hypertension: Protocol to assess comprehensively in the rat the response to pharmacologic treatments

  • Deborah Novelli,
  • Francesca Fumagalli,
  • Lidia Staszewsky,
  • Giuseppe Ristagno,
  • Davide Olivari,
  • Serge Masson,
  • Daria De Giorgio,
  • Sabina Ceriani,
  • Roberta Massafra,
  • Francesco De Logu,
  • Romina Nassini,
  • Marco Milioli,
  • Fabrizio Facchinetti,
  • Silvia Cantoni,
  • Marcello Trevisani,
  • Teresa Letizia,
  • Ilaria Russo,
  • Monica Salio,
  • Roberto Latini

Journal volume & issue
Vol. 7
p. 100771

Abstract

Read online

The identification of new treatments for primary pulmonary arterial hypertension (PAH) is a critical unmet need since there is no a definitive cure for this disease yet. Due to the complexity of PAH, a wide set of methods are necessary to assess the response to a pharmacological intervention. Thus, a rigorous protocol is crucial when experimental studies are designed. In the present experimental protocol, a stepwise approach was followed in a monocrotaline-induced PAH model in the rat, moving from the dose finding study of treatment compounds to the recognition of the onset of disease manifestation, in order to identify when to start a curative treatment. A complete multidimensional evaluation of treatment effects represented the last step. The primary study endpoint was the change in right ventricular systolic pressure after 14 days of treatment; echocardiographic and biohumoral markers together with heart and pulmonary arterial morphometric parameters were considered as secondary efficacy and/or safety endpoints and for the evaluation of the biologic coherence in the different results.

Keywords